[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.36% 1,385.00 1,380.00 1,385.00 1,415.00 1,370.00 1,400.00 11,926 16:13:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 86.4 12.6 20.0 69.3 676

Ergomed Share Discussion Threads

Showing 626 to 644 of 950 messages
Chat Pages: Latest  26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
29/6/2020
09:07
Good write up over the weekend in SCSW with a Buy rating is obviously helping the share price this morning. Excellent.
blueflame
11/6/2020
12:54
I posted yesterday to try to get some informative discussion on target prices, but so far no reaction. I have heard that pharma cos have been reporting that Covid has adversely effected clinical trials. If that were correct, then the fact that ERGO expects to meet market consensus for this year demonstrates the quality of its business. In addition, if there are Covid related problems this year, then one would expect a bounce back next year. On that basis growth could be higher than current projections. If it were 20%, then EPS would be 30p. A PEG of 1 would then imply a price of 600p. That would be a decent upside. Any thoughts?
sidam
10/6/2020
17:14
Edison say that they will update estimates and targets at the time of the trading statement due in July. If current estimates are correct, next year EPS are expected to grow by just over 16% to 28.9p. A PEG of 1 would imply a price target of about 464p. That is very decent upside if it were reached by July next year.
sidam
10/6/2020
16:34
Edison: Ergomed AGM statement AGM update: ‘Revenue growth trend’ maintained https://tinyurl.com/ybsufgbh
piedro
10/6/2020
10:16
positive AGM statement today IMHO.
mfhmfh
10/6/2020
07:06
Ergomed Plc COVID-19 Webinar: Drug Repurposing for COVID-19 https://www.youtube.com/watch?v=k9GNyLMnTXE&feature=youtu.be
piedro
05/6/2020
13:57
Ergomed@ErgomedPLC Dr. Elliot Brown of @PrimeVigilance offers his expertise to support the evaluation and interpretation of safety data from clinical studies in #covid19 as a consultant. Full article https://tinyurl.com/y9thysdv
piedro
02/6/2020
14:28
Ergomed presentation over - there were no questions.
piedro
26/5/2020
09:18
There is a free Webinar at 3pm today at which one of Ergomed's experts will be talking, see https://www.bigmarker.com/bioalliance-video-network/Ergomed-2020-05-263-2020-05-26-09-00-am?bmid=5ed921c22e7f
doog94
26/5/2020
08:39
Bought back in here chart looks good for a rise
nw99
20/5/2020
12:46
Ergomed@ErgomedPLC Clinical Trials Day is the perfect opportunity to pause a moment and pay tribute to everyone who improves #Healthcare through #clinicalresearch. Ergomed would like to acknowledge our dedicated employees and everyone who is dedicated to making the world a safer place. #CTD2020
piedro
18/5/2020
07:48
Yep, have no idea of exactly how this will work but seems to make perfect sense to use AI in a business like pharmacovigilance where you have huge volumes of data and information coming in and out and good to see Ergomed embracing the tech.
bermudashorts
18/5/2020
07:08
Nice rns- if only they provided an every day language translation. But they obviously like it!
ayl30
30/4/2020
11:01
Bought back into this earlier
montynj
29/4/2020
16:07
According to information on the Hargreaves Lansdown site , Ergomed is the tenth-biggest holding of the LF Miton UK Value Opportunities fund ( Class B Accumulation ) , constituting 2% of the fund which has a total value of £ 326 million . However , it is feasible that the information from HL is not fully up-to-date . Good luck all .
mrnumpty
06/4/2020
09:03
Also involved in a Covid-19 trial in the US (world's biggest pharma market). From RNS from 30.03.2020: '...today announces that it will provide drug safety services through its specialist pharmacovigilance provider, PrimeVigilance, for an ongoing US clinical trial to assess the effect of a rheumatoid arthritis treatment on patients with severe COVID-19 infection.'
mfhmfh
06/4/2020
08:00
Second Covid19 deal. Excellent.
blueflame
05/4/2020
08:20
Multiple posts could be malware be careful.
sidam
04/4/2020
11:27
Interesting follow up in this wknds SCSW, although those that get the heads up bought yesterday!
investographer
Chat Pages: Latest  26  25  24  23  22  21  20  19  18  17  16  15  Older
ADVFN Advertorial
Your Recent History
LSE
ERGO
Ergomed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210919 06:00:09